Skip to main content
OpenTrials
Completed

NCT Number: NCT02943863

Regional Ventilation During High Flow Nasal Cannula and Conventional Nasal Cannula in Patients With Hypoxia

High-flow nasal cannula (HFNC) that uses heated and humidified oxygen was recently introduced for bedside care. It has been shown to be associated with reduced risks of tracheal intubation rates and mortality in adult hypoxic patients.

The mechanisms of the effects of HFNC are thought to be related to the favorable effects of the heated and humidified gas, the high-flow rate used to minimize the entrainment of room air, and an increase in the ventilation efficiency, including the elimination of nasopharyngeal dead space, positive end-expiratory pressure (PEEP) effects, and improvements in paradoxical abdominal movement. Regarding the effects on lung volume, global ventilation in the lungs increases during HFNC, which is thought to attribute to PEEP effects. However, how regional ventilation is affected during HFNC in comparison with conventional NC remains unknown.

Because PEEP in mechanically ventilated patients improves the regional homogeneity of ventilation, investigators postulated that HFNC via PEEP effects would result in more homogeneous regional distributions in the ventilation changes. Investigators therefore assessed global and regional ventilation in patients with hypoxia receiving care via HFNC using electric impedance tomography and compared these results with conventional nasal cannula.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age >20 years
  • Subjective dyspnea in room air
  • SaO2< 90% in room air
  • Oxygen requirement for nasal cannula < 6 L/m

Exclusion criteria

  • Unstable vital signs
  • SBP <90 mmHg
  • DBP < 60 mmHg
  • Heart rate > 120 bpm
  • Respiratory rate > 30 bpm
  • Persistent dyspnea under oxygen therapy using NC
  • Severe hypoxia
  • PaO2/FiO2< 200 mmHg
  • Unable to cooperate
  • Delirium
  • Reduced cognitive function

Treatment and study plan

HFNC followed by conventional nasal cannula

Device

Conventional nasal cannula followed by HFNC

Device

Primary outcomes

  1. Tidal variation

    Time frame: Twenty minutes after each oxygen therapy. (At the end of each oxygen therapy)

    Tidal variation using electric impedance tomography

Secondary outcomes

  1. Oxygen saturation

    Time frame: Twenty minutes after each oxygen therapy. (At the end of each oxygen therapy)

    Oxygen saturation at using pulse oxymeter

  2. Respiration Rate

    Time frame: Twenty minutes after each oxygen therapy. (At the end of each oxygen therapy)

  3. Subjective comfort

    Time frame: Twenty minutes after each oxygen therapy. (At the end of each oxygen therapy)

    Subjective comfort using questionnaire

Sponsors and collaborators

Lead sponsor

Asan Medical Center

Other

Collaborators

  • Ministry of Trade, Industry & Energy, Republic of Korea

Registry information

Official study title

Comparison of Regional Ventilation Pattern During High Flow Nasal Cannula Between Conventional Low Flow System Nasal Cannula in Patients With Mild to Moderate Hypoxia

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Oct 25, 2016
Registry last updated
Oct 25, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.